Verona Pharma plc - Depositary Receipt (Common Stock)
US ˙ NasdaqGM ˙ US9250501064

Introduction

This page provides a comprehensive analysis of the known insider trading history of Mark W Hahn. Insiders are officers, directors, or significant investors in a company. It is illegal for insiders to make trades in their companies based on specific, non-public information. This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4. Despite these restrictions, academic research suggests that insiders - in general - tend to outperform the market in their own companies.

Average Trade Profitability

The average trade profitability is the average return of all the open market purchases made by the insider in the last three years. To calculate this, we examine every open-market, unplanned purchase made by the insider, excluding all trades that were marked as part of a 10b5-1 trading plan. We then calculate the average performance of those trades over 3, 6, and 12 months, averaging each of those durations to generate a final performance metric for each trade. Finally, we average all of the performance metrics to calculate a performance metric for the insider. This list only includes insiders that have made at least three trades in the last two years.

If this insiders trade profitability is "N/A", then the insider either has not made any open-market purchases in the last three years, or the trades they’ve made are too recent to calculate a reliable performance metric.

Update Frequency: Daily

See the list of most profitable insider traders.

Companies with Reported Insider Positions

The SEC filings indicate Mark W Hahn has reported holdings or trades in the following companies:

Security Title Latest Reported Holdings
US:VRNA / Verona Pharma plc - Depositary Receipt (Common Stock) Chief Financial Officer 11,264,968
US:ALOR / ALSP Orchid Acquisition Corp I - Class A Director 0
US:DOVA / Dova Pharmaceuticals, Inc. Chief Financial Officer 0
US:CEMP / Cempra, Inc. EVP and CFO 25,000
How to Interpret the Charts

The following charts show the stock performance of securities subsequent to each open-market, non-planned trade made by Mark W Hahn. Non-planned trade are trades that were not made as part of a 10b5-1 trading plan. The stock performance is charted as cumulative percent change in share price. For example, if an insider trade was made on January 1, 2019, the chart will show the daily percent change of the security to the present day. If the share price were to go from $10 to $15 during this time, the cumulative percent change in share price would be 50%. A change in price from $10 to $20 would be 100%, and a change in price of $10 to $5 would be -50%.

Ultimately, we are trying to determine how closely the insider’s trades correlate to excess returns (positive or negative) in the share price in order to see if the insider is timing their trades to profit from insider information. Consider the situation where an insider was doing this. In this situation, we would expect either (a) positive returns after purchases, or (b) negative returns after sales. In the case of (a), the PURCHASE chart would show a series of upwardly sloping curves, indicating positive returns after each purchase transaction. In the case of (b), the SALE chart would show a series of downward sloping curves, indicating negative returns after each sale transaction.

However, this alone is not enough to draw conclusions. If, for example, the share price of the company was in a non-cyclical climb over many years, then we would expect all the post-purchase plots to be upwardly sloping. Likewise, non-cyclical declines over many years would result in downward sloping post-trade plots. Neither of these charts would suggest insider trading activity.

The strongest indicator would be a situation where the share price was extremely cyclical, and there were both positive signals in the PURCHASE chart and negative plots on the SALE chart. This situation would be highly suggestive of an insider that was timing trades to their financial advantage.

Insider Purchases VRNA / Verona Pharma plc - Depositary Receipt (Common Stock) - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made in VRNA / Verona Pharma plc - Depositary Receipt (Common Stock). This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Max
Price at
Max
Max
Profit ($)
Max Return (%)
There are no known unplanned open-market trades for this insider and security combination

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

VRNA / Verona Pharma plc - Depositary Receipt (Common Stock) Insider Trades
Insider Sales VRNA / Verona Pharma plc - Depositary Receipt (Common Stock) - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made in VRNA / Verona Pharma plc - Depositary Receipt (Common Stock). A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market sales that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Min
Price at
Min
Max Loss
Avoided ($)
Max Loss
Avoided (%)
There are no known unplanned open-market trades for this insider and security combination

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

VRNA / Verona Pharma plc - Depositary Receipt (Common Stock) Insider Trades
Insider Trading History

This table shows the complete list of insider trades made by Mark W Hahn as disclosed to the Securities Exchange Commission (SEC).

File Date Tran Date Form Ticker Security Code 10b5-1 Shares Remaining Shares Percent
Change
Share
Price
Tran
Value
Remaining
Value
2025-09-03 2025-08-29 4 VRNA Verona Pharma plc
Ordinary Shares
G - Gift -1,200,000 11,264,968 -9.63
2025-08-05 2025-08-01 4 VRNA Verona Pharma plc
Ordinary Shares
S - Sale X -208,912 12,464,968 -1.65 13.14 -2,745,877 163,835,800
2025-08-05 2025-08-01 4 VRNA Verona Pharma plc
Ordinary Shares
M - Exercise 255,696 12,673,880 2.06
2025-07-09 2025-07-08 4 VRNA Verona Pharma plc
Ordinary Shares
F - Taxes -90,320 12,418,184 -0.72 11.44 -1,033,378 142,080,169
2025-07-09 2025-07-07 4 VRNA Verona Pharma plc
Ordinary Shares
M - Exercise 229,512 12,508,504 1.87
2025-06-13 2025-06-11 4 VRNA Verona Pharma plc
Ordinary Shares
S - Sale X -400,000 12,278,992 -3.15 11.40 -4,560,360 139,991,560
2025-05-29 2025-05-29 4 VRNA Verona Pharma plc
Ordinary Shares
S - Sale X -204,864 12,678,992 -1.59 9.33 -1,911,668 118,312,746
2025-05-29 2025-05-28 4 VRNA Verona Pharma plc
Ordinary Shares
S - Sale X -162,704 12,883,856 -1.25 9.30 -1,513,294 119,831,456
2025-05-29 2025-05-27 4 VRNA Verona Pharma plc
Ordinary Shares
S - Sale X -32,432 13,046,560 -0.25 9.53 -308,983 124,295,882
2025-05-05 2025-05-02 4 VRNA Verona Pharma plc
Ordinary Shares
S - Sale X -400,000 13,078,992 -2.97 9.09 -3,637,720 118,944,277
2025-05-05 2025-05-01 4 VRNA Verona Pharma plc
Ordinary Shares
S - Sale X -78,736 13,478,992 -0.58 8.95 -704,703 120,639,674
2025-05-05 2025-05-01 4 VRNA Verona Pharma plc
Ordinary Shares
M - Exercise 200,000 13,557,728 1.50
2025-05-05 2025-05-01 4 VRNA Verona Pharma plc
Ordinary Shares
S - Sale X -108,272 13,357,728 -0.80 8.95 -969,056 119,554,337
2025-05-01 2025-04-29 4 VRNA Verona Pharma plc
Ordinary Shares
S - Sale X -90,360 13,466,000 -0.67 8.98 -811,433 120,924,680
2025-05-01 2025-04-29 4 VRNA Verona Pharma plc
Ordinary Shares
M - Exercise 229,512 13,556,360 1.72
2025-02-04 2025-02-03 4 VRNA Verona Pharma plc
Ordinary Shares
F - Taxes -166,888 13,326,848 -1.24 7.16 -1,195,335 95,453,549
2025-02-04 2025-02-01 4 VRNA Verona Pharma plc
Ordinary Shares
A - Award 200,000 13,493,736 1.50
2024-12-06 2024-12-06 4 VRNA Verona Pharma plc
Ordinary Shares
S - Sale X -183,728 13,293,736 -1.36 5.01 -920,312 66,589,653
2024-12-06 2024-12-05 4 VRNA Verona Pharma plc
Ordinary Shares
S - Sale X -640,048 13,477,464 -4.53 5.01 -3,204,144 67,469,533
2024-12-06 2024-12-04 4 VRNA Verona Pharma plc
Ordinary Shares
S - Sale X -58,184 14,117,512 -0.41 5.00 -290,996 70,605,913
2024-12-02 2024-12-02 4 VRNA Verona Pharma plc
Ordinary Shares
S - Sale X -1,600 14,175,696 -0.01 5.00 -8,000 70,878,480
2024-12-02 2024-11-29 4 VRNA Verona Pharma plc
Ordinary Shares
S - Sale X -98,704 14,177,296 -0.69 5.01 -494,142 70,975,797
2024-12-02 2024-11-27 4 VRNA Verona Pharma plc
Ordinary Shares
S - Sale X -12,936 14,276,000 -0.09 5.00 -64,680 71,380,000
2024-11-26 2024-11-26 4 VRNA Verona Pharma plc
Ordinary Shares
S - Sale X -800 14,288,936 -0.01 5.00 -4,000 71,444,680
2024-11-26 2024-11-25 4 VRNA Verona Pharma plc
Ordinary Shares
S - Sale X -1,600 14,289,736 -0.01 5.00 -8,000 71,448,680
2024-11-13 2024-11-11 4 VRNA Verona Pharma plc
Ordinary Shares
S - Sale X -2,400 14,291,336 -0.02 5.00 -12,000 71,456,680
2024-11-05 2024-11-04 4 VRNA Verona Pharma plc
Ordinary Shares
S - Sale X -80,784 14,293,736 -0.56 4.39 -354,448 62,715,196
2024-11-05 2024-11-01 4 VRNA Verona Pharma plc
Ordinary Shares
S - Sale X -48,888 14,374,520 -0.34 4.38 -213,939 62,904,337
2024-11-01 2024-11-01 4 VRNA Verona Pharma plc
Ordinary Shares
F - Taxes -245,952 14,423,408 -1.68 4.24 -1,043,132 61,172,558
2024-11-01 2024-11-01 4 VRNA Verona Pharma plc
Ordinary Shares
A - Award 200,000 14,669,360 1.38
2024-11-01 2024-10-30 4 VRNA Verona Pharma plc
Ordinary Shares
A - Award 800,000 14,469,360 5.85
2024-10-25 2024-10-25 4 VRNA Verona Pharma plc
Ordinary Shares
S - Sale X -3,200 13,669,360 -0.02 4.38 -14,000 59,803,450
2024-10-25 2024-10-24 4 VRNA Verona Pharma plc
Ordinary Shares
S - Sale X -141,360 13,672,560 -1.02 4.38 -618,761 59,847,530
2024-10-22 2024-10-22 4 VRNA Verona Pharma plc
Ordinary Shares
S - Sale X -159,344 13,813,920 -1.14 4.38 -698,708 60,572,658
2024-10-22 2024-10-21 4 VRNA Verona Pharma plc
Ordinary Shares
S - Sale X -116,696 13,973,264 -0.83 4.38 -511,082 61,197,307
2024-10-22 2024-10-18 4 VRNA Verona Pharma plc
Ordinary Shares
S - Sale X -249,728 14,089,960 -1.74 4.38 -1,093,983 61,723,888
2024-09-13 2024-09-11 4 VRNA Verona Pharma plc
Ordinary Shares
S - Sale X -600,000 14,339,688 -4.02 3.76 -2,254,080 53,871,340
2024-08-14 2024-08-13 4 VRNA Verona Pharma plc
Ordinary Shares
S - Sale X -3,736 14,939,688 -0.03 3.25 -12,142 48,553,986
2024-08-14 2024-08-13 4 VRNA Verona Pharma plc
Ordinary Shares
S - Sale X -394,664 14,943,424 -2.57 3.20 -1,263,398 47,836,889
2024-08-14 2024-08-12 4 VRNA Verona Pharma plc
Ordinary Shares
S - Sale X -1,600 15,338,088 -0.01 3.13 -5,008 48,008,215
2024-08-09 2024-08-07 4 VRNA Verona Pharma plc
Ordinary Shares
F - Taxes -314,800 15,339,688 -2.01 2.62 -824,776 40,189,983
2024-08-09 2024-08-07 4 VRNA Verona Pharma plc
Ordinary Shares
A - Award 800,000 15,654,488 5.39
2024-08-05 2024-08-01 4 VRNA Verona Pharma plc
Ordinary Shares
F - Taxes -88,544 14,854,488 -0.59 2.83 -250,801 42,075,337
2024-05-03 2024-05-01 4 VRNA Verona Pharma plc
Ordinary Shares
F - Taxes -88,544 14,943,032 -0.59 1.93 -171,005 28,859,478
2024-02-05 2024-02-01 4 VRNA Verona Pharma plc
Ordinary Shares
F - Taxes -480,664 15,031,576 -3.10 2.29 -1,102,547 34,479,429
2023-11-03 2023-11-01 4 VRNA Verona Pharma plc
Ordinary Shares
F - Taxes -809,008 15,512,240 -4.96 1.74 -1,410,748 27,050,244
2023-10-24 2023-10-20 4 VRNA Verona Pharma plc
Ordinary Shares
A - Award 800,000 16,321,248 5.15
2023-08-07 2023-08-07 4 VRNA Verona Pharma plc
Ordinary Shares
S - Sale X -8,616 15,521,248 -0.06 2.47 -21,263 38,304,888
2023-08-07 2023-08-04 4 VRNA Verona Pharma plc
Ordinary Shares
S - Sale X -150,000 15,529,864 -0.96 2.50 -374,880 38,812,236
2023-08-07 2023-08-03 4 VRNA Verona Pharma plc
Ordinary Shares
S - Sale X -117,272 15,679,864 -0.74 2.54 -297,754 39,811,175
2023-08-03 2023-08-02 4 VRNA Verona Pharma plc
Ordinary Shares
S - Sale X -73,704 15,797,136 -0.46 2.59 -191,114 40,961,974
2023-08-03 2023-08-01 4 VRNA Verona Pharma plc
Ordinary Shares
S - Sale X -105,944 15,870,840 -0.66 2.68 -283,824 42,517,980
2023-05-03 2023-05-01 4 VRNA Verona Pharma plc
Ordinary Shares
S - Sale X -455,528 15,976,784 -2.77 2.58 -1,173,395 41,154,598
2023-02-03 2023-02-01 4 VRNA Verona Pharma plc
Ordinary Shares
S - Sale X -413,168 16,432,312 -2.45 2.56 -1,056,553 42,020,708
2022-12-21 2022-12-20 4 VRNA Verona Pharma plc
Ordinary Shares
S - Sale X -600,000 16,845,480 -3.44 2.12 -1,269,060 35,629,875
2022-11-03 2022-11-01 4 VRNA Verona Pharma plc
Ordinary Shares
S - Sale X -13,160 17,445,480 -0.08 1.67 -22,011 29,179,310
2022-11-03 2022-11-01 4 VRNA Verona Pharma plc
Ordinary Shares
F - Taxes -454,856 17,458,640 -2.54 1.60 -727,770 27,933,824
2022-09-28 2022-09-26 4 VRNA Verona Pharma plc
Ordinary Shares
A - Award 3,600,000 17,913,496 25.15
2022-08-11 2022-08-09 4 VRNA Verona Pharma plc
Ordinary Shares
S - Sale X -600,000 14,313,496 -4.02 1.75 -1,050,000 25,048,618
2022-08-03 2022-08-01 4 VRNA Verona Pharma plc
Ordinary Shares
S - Sale X -13,168 14,913,496 -0.09 0.70 -9,215 10,436,465
2022-08-03 2022-08-01 4 VRNA Verona Pharma plc
Ordinary Shares
F - Taxes -454,856 14,926,664 -2.96 0.67 -305,891 10,038,182
2022-05-05 2022-05-03 4 VRNA Verona Pharma plc
Ordinary Shares
S - Sale X -12,512 15,381,520 -0.08 0.50 -6,201 7,623,081
2022-05-03 2022-05-01 4 VRNA Verona Pharma plc
Ordinary Shares
F - Taxes -432,128 15,394,032 -2.73 0.52 -225,787 8,043,382
2022-02-03 2022-02-02 4 VRNA Verona Pharma plc
Ordinary Shares
S - Sale X -10,416 15,826,160 -0.07 0.76 -7,877 11,967,742
2022-02-03 2022-02-01 4 VRNA Verona Pharma plc
Ordinary Shares
F - Taxes -288,320 15,836,576 -1.79 0.78 -223,794 12,292,350
2022-02-03 2022-02-01 4 VRNA Verona Pharma plc
Ordinary Shares
A - Award 133,776 16,124,896 0.84 0.75 99,998 12,053,360
2021-11-18 3 ALOR ALSP Orchid Acquisition Corp I
No securities are beneficially owned
0
2021-11-03 2021-11-02 4 VRNA Verona Pharma plc
Ordinary Shares
S - Sale X -10,416 15,991,120 -0.07 0.65 -6,721 10,319,070
2021-11-03 2021-11-01 4 VRNA Verona Pharma plc
Ordinary Shares
F - Taxes -454,848 16,001,536 -2.76 0.64 -291,103 10,240,983
2021-08-03 2021-08-02 4 VRNA Verona Pharma plc
Ordinary Shares
S - Sale X -10,416 16,456,384 -0.06 0.77 -7,989 12,622,047
2021-08-03 2021-08-01 4 VRNA Verona Pharma plc
Ordinary Shares
F - Taxes -454,840 16,466,800 -2.69 0.78 -357,049 12,926,438
2021-05-05 2021-05-03 4 VRNA Verona Pharma plc
Ordinary Shares
S - Sale X -10,416 16,921,640 -0.06 0.87 -9,094 14,774,284
2021-05-05 2021-05-03 4 VRNA Verona Pharma plc
Ordinary Shares
F - Taxes -2,122,448 16,932,056 -11.14 0.89 -1,883,673 15,027,200
2021-03-03 2021-03-01 4 VRNA Verona Pharma plc
Ordinary Shares
S - Sale X -26,728 19,054,504 -0.14 1.14 -30,571 21,794,542
2021-02-01 2021-01-28 4 VRNA Verona Pharma plc
Ordinary Shares
A - Award 105,824 19,081,232 0.56
2021-01-04 3 VRNA Verona Pharma plc
Ordinary Shares
18,975,408
2019-11-12 2019-11-12 4 DOVA Dova Pharmaceuticals Inc.
Employee Stock Option (Right to Buy)
D - Sale to Issuer -250,000 0 -100.00
2019-11-12 2019-11-12 4 DOVA Dova Pharmaceuticals Inc.
Employee Stock Option (Right to Buy)
D - Sale to Issuer -50,000 0 -100.00
2019-11-12 2019-11-12 4 DOVA Dova Pharmaceuticals Inc.
Common Stock
D - Sale to Issuer -9,024 0 -100.00
2019-10-02 2019-09-30 4 DOVA Dova Pharmaceuticals Inc.
Common Stock
S - Sale X -775 9,024 -7.91 28.00 -21,700 252,672
2019-07-02 2019-07-01 4 DOVA Dova Pharmaceuticals Inc.
Common Stock
S - Sale X -1,545 9,799 -13.62 14.17 -21,893 138,852
2019-01-08 2019-01-04 4 DOVA Dova Pharmaceuticals Inc.
Employee Stock Option (right to buy)
A - Award 250,000 250,000
2019-01-08 2019-01-04 4 DOVA Dova Pharmaceuticals Inc.
Common Stock
A - Award 8,844 11,344 353.76
2018-12-21 2018-12-19 4 DOVA Dova Pharmaceuticals Inc.
Common Stock
P - Purchase 2,500 2,500 6.28 15,700 15,700
2018-10-10 2018-10-08 4 DOVA Dova Pharmaceuticals Inc.
Employee Stock Option (Right to Buy)
A - Award 50,000 50,000
2018-02-01 2018-01-31 4 DOVA Dova Pharmaceuticals, Inc.
Employee Stock Option (Right to Buy)
A - Award 175,000 175,000
2018-02-01 3 DOVA Dova Pharmaceuticals, Inc.
Common Stock
0
2017-02-27 2017-02-23 4 CEMP CEMPRA, INC.
Employee Stock Option (Right to Buy)
A - Award 25,000 25,000
2017-02-27 2017-02-23 4 CEMP CEMPRA, INC.
Restricted Stock Units
A - Award 25,000 25,000
2017-01-05 2017-01-03 4 CEMP CEMPRA, INC.
Restricted Stock Units
A - Award 50,000 50,000
2017-01-05 2017-01-03 4 CEMP CEMPRA, INC.
Employee Stock Option (Right to Buy)
A - Award 125,000 125,000
2016-01-05 2016-01-01 4 CEMP CEMPRA, INC.
Employee Stock Option (Right to Buy)
A - Award 59,660 59,660
2015-01-02 2015-01-01 4 CEMP CEMPRA, INC.
Employee Stock Option (Right to Buy)
A - Award 46,363 46,363
2014-01-10 2014-01-08 4 CEMP CEMPRA, INC.
Employee Stock Option (Right to Buy)
A - Award 45,000 45,000
2014-01-10 2014-01-08 4 CEMP CEMPRA, INC.
Employee Stock Option (Right to Buy)
A - Award 15,000 15,000
2013-01-22 2013-01-18 4 CEMP CEMPRA, INC.
Employee Stock Option (Right to Buy)
A - Award 50,000 50,000
2012-03-22 2012-03-20 4 CEMP CEMPRA, INC.
Employee Stock Option (Right to Buy)
A - Award 25,000 25,000
2012-02-03 3 CEMP Cempra Holdings, LLC
None
0
P
Open market or private purchase of non-derivative or derivative security
S
Open market or private sale of non-derivative or derivative security
A
Grant, award, or other acquisition of securities from the company (such as an option)
C
Conversion of derivative
D
Sale or transfer of securities back to the company
F
Payment of exercise price or tax liability using portion of securities received from the company
G
Gift of securities by or to the insider
K
Equity swaps and similar hedging transactions
M
Exercise or conversion of derivative security received from the company (such as an option)
V
A transaction voluntarily reported on Form 4
J
Other (accompanied by a footnote describing the transaction)